Alligator Bioscience AB (publ) (STO:ATORX)
3.700
-0.069 (-1.83%)
Jun 13, 2025, 5:29 PM CET
Alligator Bioscience AB Revenue
Alligator Bioscience AB had revenue of 319.00K SEK in the quarter ending March 31, 2025, a decrease of -95.47%. This brings the company's revenue in the last twelve months to 51.00M, down -9.70% year-over-year. In the year 2024, Alligator Bioscience AB had annual revenue of 57.72M, down -2.58%.
Revenue (ttm)
51.00M
Revenue Growth
-9.70%
P/S Ratio
2.52
Revenue / Employee
1.55M
Employees
45
Market Cap
128.77M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 57.72M | -1.53M | -2.58% |
Dec 31, 2023 | 59.25M | 23.25M | 64.58% |
Dec 31, 2022 | 36.00M | 22.67M | 170.14% |
Dec 31, 2021 | 13.33M | 7.81M | 141.65% |
Dec 31, 2020 | 5.52M | 1.16M | 26.55% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.31B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Camurus AB | 2.04B |
Medicover AB | 23.56B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |